<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; Freebies</title>
	<atom:link href="http://www.tapanray.in/tag/freebies/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>Digital Marketing: Is Pharma Still A Laggard?</title>
		<link>http://www.tapanray.in/digital-marketing-is-pharma-still-a-laggard/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=digital-marketing-is-pharma-still-a-laggard</link>
		<comments>http://www.tapanray.in/digital-marketing-is-pharma-still-a-laggard/#comments</comments>
		<pubDate>Mon, 17 Aug 2015 00:00:16 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[AstraZeneca]]></category>
		<category><![CDATA[Boehringer Ingelheim]]></category>
		<category><![CDATA[brand]]></category>
		<category><![CDATA[Cephalon]]></category>
		<category><![CDATA[digital]]></category>
		<category><![CDATA[Freebies]]></category>
		<category><![CDATA[GSK]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[laggard]]></category>
		<category><![CDATA[Maggi]]></category>
		<category><![CDATA[Maggie]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[Merck]]></category>
		<category><![CDATA[Nestle]]></category>
		<category><![CDATA[nexium]]></category>
		<category><![CDATA[Novartis]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Salford Business School]]></category>
		<category><![CDATA[Sanofi]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[UCB]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=6946</guid>
		<description><![CDATA[‘Brand Marketing’ in the pharmaceutical industry, across the world, has mostly remained tradition bound, despite its rapid embracement of modern state of the art tools and technology in most other areas of the business. Many other industries have been demonstrating &#8230; <a href="http://www.tapanray.in/digital-marketing-is-pharma-still-a-laggard/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/digital-marketing-is-pharma-still-a-laggard/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Finance Ministry Disallows Expenses on &#8216;Freebies&#8217; to Doctors by Pharma Companies in line with MCI Guidelines: A Possible Game Changer?</title>
		<link>http://www.tapanray.in/finance-ministry-disallows-expenses-on-freebies-to-doctors-by-pharma-companies-in-line-with-mci-guidelines-a-possible-game-changer/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=finance-ministry-disallows-expenses-on-freebies-to-doctors-by-pharma-companies-in-line-with-mci-guidelines-a-possible-game-changer</link>
		<comments>http://www.tapanray.in/finance-ministry-disallows-expenses-on-freebies-to-doctors-by-pharma-companies-in-line-with-mci-guidelines-a-possible-game-changer/#comments</comments>
		<pubDate>Mon, 06 Aug 2012 00:00:12 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[by]]></category>
		<category><![CDATA[Changer]]></category>
		<category><![CDATA[companies]]></category>
		<category><![CDATA[Disallows]]></category>
		<category><![CDATA[doctors]]></category>
		<category><![CDATA[Expenses]]></category>
		<category><![CDATA[Finance]]></category>
		<category><![CDATA[Freebies]]></category>
		<category><![CDATA[Game]]></category>
		<category><![CDATA[Guidelines]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[line]]></category>
		<category><![CDATA[MCI]]></category>
		<category><![CDATA[Ministry]]></category>
		<category><![CDATA[on]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Possible]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[to]]></category>
		<category><![CDATA[with]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=56</guid>
		<description><![CDATA[Things are unfolding reasonably faster now related to the financial relationship between the pharmaceutical companies and the medical profession. All these issues are getting increasingly dragged into the public debate where government can no longer play the role of a &#8230; <a href="http://www.tapanray.in/finance-ministry-disallows-expenses-on-freebies-to-doctors-by-pharma-companies-in-line-with-mci-guidelines-a-possible-game-changer/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/finance-ministry-disallows-expenses-on-freebies-to-doctors-by-pharma-companies-in-line-with-mci-guidelines-a-possible-game-changer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
